 U.S.
FDA leaning toward approving Moderna half-dose booster -Bloomberg News
Send a link to a friend
[September 29, 2021]
(Reuters) -The U.S. Food and Drug
Administration (FDA) is leaning toward authorizing half-dose booster
shots of the Moderna Inc COVID-19 vaccine, Bloomberg News reported
https://bloom.bg/3EXGHjA on Tuesday, citing people familiar with the
matter.
|
|
 The FDA had been seeking information about the effectiveness of a
full third dose of the Moderna vaccine, but is now ready to move
forward and consider the half-dose booster Moderna has proposed, the
report said.
Moderna and the FDA did not immediately respond to Reuters request
for comment outside regular business hours.
Moderna on Sept. 1 submitted its application to the U.S. Food and
Drug Administration seeking authorization for a booster shot.
[to top of second column] |
The original Moderna vaccine contains 100-micrograms of mRNA in each
shot. The company's submission to regulators to authorize a
half-dose booster would allow Moderna to produce more.
(Reporting by Akriti Sharma in Bengaluru; Editing by Muralikumar
Anantharaman)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
